Table 1.
Characteristics of the overall cohort
Variable | Participants (N = 147) |
---|---|
Demographic | |
Age (y) | 75 ± 8.659 |
Female | 66 (44.6) |
Primary admission diagnosis | |
Ischemic heart disease | 72 (48.6) |
Heart failure | 19 (12.8) |
Arrhythmia | 22 (14.8) |
Valvular disease | 8 (5.4) |
Other∗ | 27 (18.4) |
Clinical | |
CICU length of stay, d | 3.4 |
Hospital length of stay, d | 7.00 |
Mobility | |
Pre-hospitalization LOF | 0.5 |
Admission LOF | 1.3 |
CICU discharge LOF | 0.7 |
Mobility activities / activities possible | 87.0 (1835/2109) |
Mobility opportunities used / total opportunities, % (n/n) | 93.2 (655/703) |
Adverse events | 8 (0.4) |
Contraindications to mobilization | 27 (20.3) |
Contraindications and eventual mobilization | 27 (100) |
Values are M ± SD, or n (%), unless otherwise indicated.
CV, cardiovascular; CICU, cardiovascular intensive care unit; LOF, level of function
The LOF score ranges from 0 (maintain range of motion) to 5 (increase general endurance and mobility).
Myocarditis, n = 4; pericardial disease, n = 4; pulmonary hypertension, n = 4; cardiomyopathy, n = 3; hypertension, n = 3; cancer, n = 2; hypertrophic cardiomyopathy, n = 2; infection, n = 2; aortic dissection, n = 1; drug toxicity, n = 1; electronic device complications, n = 1.